CME Group reports Q3 earnings beat despite revenue decline, highlighting market data revenue growth and shareholder returns.
Lancet study finds clinically significant, drug-specific differences in weight, heart rate, and blood pressure among 30 antidepressants, highlighting the importance of individualizing treatment and routine physical monitoring.
CME Group reports Q3 earnings beat despite revenue decline, highlighting market data revenue growth and shareholder returns.
Lancet study finds clinically significant, drug-specific differences in weight, heart rate, and blood pressure among 30 antidepressants, highlighting the importance of individualizing treatment and routine physical monitoring.